Borroni B - Search Results

1

Structural brain signature of FTLD driven by Granulin mutation.

Bozzali M, Battistoni V, Premi E, Alberici A, Giulietti G, Archetti S, Turla M, Gasparotti R, Cercignani M, Padovani A, Borroni B. Bozzali M, et al. Among authors: borroni b. J Alzheimers Dis. 2013;33(2):483-94. doi: 10.3233/JAD-2012-121273. J Alzheimers Dis. 2013. PMID: 22986778

2

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.

Borroni B, Colciaghi F, Pastorino L, Archetti S, Corsini P, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Eur Neuropsychopharmacol. 2002 Jun;12(3):195-200. doi: 10.1016/s0924-977x(02)00013-5. Eur Neuropsychopharmacol. 2002. PMID: 12007670

3

Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction.

Borroni B, Volpi R, Martini G, Del Bono R, Archetti S, Colciaghi F, Akkawi NM, Di Luca M, Romanelli G, Caimi L, Padovani A. Borroni B, et al. Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):150-5. doi: 10.1097/00002093-200207000-00004. Alzheimer Dis Assoc Disord. 2002. PMID: 12218645

4

Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study.

Borroni B, Colciaghi F, Caltagirone C, Rozzini L, Broglio L, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Arch Neurol. 2003 Dec;60(12):1740-4. doi: 10.1001/archneur.60.12.1740. Arch Neurol. 2003. PMID: 14676049

5

Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.

Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Caimi L, Caltagirone C, Di Luca M, Padovani A. Borroni B, et al. Neurobiol Aging. 2004 Jul;25(6):747-51. doi: 10.1016/j.neurobiolaging.2003.08.004. Neurobiol Aging. 2004. PMID: 15165699 Free article.

6

Predicting cognitive decline in Alzheimer disease. Role of platelet amyloid precursor protein.

Borroni B, Colciaghi F, Archetti S, Marcello E, Caimi L, Di Luca M, Padovani A. Borroni B, et al. Alzheimer Dis Assoc Disord. 2004 Jan-Mar;18(1):32-4. doi: 10.1097/00002093-200401000-00006. Alzheimer Dis Assoc Disord. 2004. PMID: 15195460

7

Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease.

Borroni B, Agosti C, Archetti S, Costanzi C, Bonomi S, Ghianda D, Lenzi GL, Caimi L, Di Luca M, Padovani A. Borroni B, et al. Neurosci Lett. 2004 Nov 11;370(2-3):127-9. doi: 10.1016/j.neulet.2004.08.006. Neurosci Lett. 2004. PMID: 15488308

8

Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patients.

Borroni B, Agosti C, Martini G, Volpi R, Brambilla C, Caimi L, Di Luca M, Padovani A. Borroni B, et al. J Neurol Sci. 2005 Mar 15;229-230:211-3. doi: 10.1016/j.jns.2004.11.030. Epub 2004 Dec 8. J Neurol Sci. 2005. PMID: 15760641

9

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.

Zimmermann M, Borroni B, Cattabeni F, Padovani A, Di Luca M. Zimmermann M, et al. Among authors: borroni b. Neurobiol Dis. 2005 Jun-Jul;19(1-2):237-42. doi: 10.1016/j.nbd.2005.01.002. Neurobiol Dis. 2005. PMID: 15837579

10

Advances on biological markers in early diagnosis of Alzheimer disease.

Padovani A, Borroni B, Di Luca M. Padovani A, et al. Among authors: borroni b. Adv Clin Chem. 2005;39:107-29. doi: 10.1016/s0065-2423(04)39004-9. Adv Clin Chem. 2005. PMID: 16013669 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters